These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1759150)
1. [Detection of lysergic acid diethylamide in human urine: elimination, screening and analytical confirmation]. Vu-Duc T; Vernay A; Calanca A Schweiz Med Wochenschr; 1991 Dec; 121(50):1887-90. PubMed ID: 1759150 [TBL] [Abstract][Full Text] [Related]
2. The analysis of lysergide (LSD): the development of novel enzyme immunoassay and immunoaffinity extraction procedures together with an HPLC-MS confirmation procedure. Webb KS; Baker PB; Cassells NP; Francis JM; Johnston DE; Lancaster SL; Minty PS; Reed GD; White SA J Forensic Sci; 1996 Nov; 41(6):938-46. PubMed ID: 8914284 [TBL] [Abstract][Full Text] [Related]
3. An online immunoassay for LSD: comparison with GC-MS and the Abuscreen RIA. McNally AJ; Goc-Szkutnicka K; Li Z; Pilcher I; Polakowski S; Salamone SJ J Anal Toxicol; 1996 Oct; 20(6):404-8. PubMed ID: 8889676 [TBL] [Abstract][Full Text] [Related]
4. Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD. Poch GK; Klette KL; Hallare DA; Manglicmot MG; Czarny RJ; McWhorter LK; Anderson CJ J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):23-33. PubMed ID: 10202954 [TBL] [Abstract][Full Text] [Related]
5. Determination of LSD in urine by capillary column gas chromatography and electron impact mass spectrometry. Francom P; Andrenyak D; Lim HK; Bridges RR; Foltz RL; Jones RT J Anal Toxicol; 1988; 12(1):1-8. PubMed ID: 3352236 [TBL] [Abstract][Full Text] [Related]
6. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples. Wiegand RF; Klette KL; Stout PR; Gehlhausen JM J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010 [TBL] [Abstract][Full Text] [Related]
7. Quantitation of lysergic acid diethylamide in urine using atmospheric pressure matrix-assisted laser desorption/ionization ion trap mass spectrometry. Cui M; McCooeye MA; Fraser C; Mester Z Anal Chem; 2004 Dec; 76(23):7143-8. PubMed ID: 15571372 [TBL] [Abstract][Full Text] [Related]
8. Automated extraction of lysergic acid diethylamide (LSD) and N-demethyl-LSD from blood, serum, plasma, and urine samples using the Zymark RapidTrace with LC/MS/MS confirmation. de Kanel J; Vickery WE; Waldner B; Monahan RM; Diamond FX J Forensic Sci; 1998 May; 43(3):622-5. PubMed ID: 9608700 [TBL] [Abstract][Full Text] [Related]
9. Detection of lysergic acid diethylamide (LSD) in urine by gas chromatography-ion trap tandem mass spectrometry. Sklerov JH; Kalasinsky KS; Ehorn CA J Anal Toxicol; 1999 Oct; 23(6):474-8. PubMed ID: 10517553 [TBL] [Abstract][Full Text] [Related]
10. The determination of lysergide (LSD) in urine by high-performance liquid chromatography-isotope dilution mass spectrometry (IDMS). White SA; Kidd AS; Webb KS J Forensic Sci; 1999 Mar; 44(2):375-9. PubMed ID: 10097366 [TBL] [Abstract][Full Text] [Related]
11. Gas chromatographic-electron-impact mass fragmentometric determination of lysergic acid diethylamide in urine. Paul BD; Mitchell JM; Burbage R; Moy M; Sroka R J Chromatogr; 1990 Jul; 529(1):103-12. PubMed ID: 2211923 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the diagnostic performance of the Boehringer Mannheim CEDIA LSD assay. Verstraete AG; Steyaert S J Anal Toxicol; 1998; 22(7):601-4. PubMed ID: 9847012 [TBL] [Abstract][Full Text] [Related]
13. Detection and interpretation of lysergic acid diethylamide results by immunoassay screening of urine in various testing groups. Wu AH; Feng YJ; Pajor A; Gornet TG; Wong SS; Forte E; Brown J J Anal Toxicol; 1997; 21(3):181-4. PubMed ID: 9171199 [TBL] [Abstract][Full Text] [Related]
14. Confirmation of Syva enzyme multiple immunoassay technique (EMIT) d.a.u. and Roche Abuscreen radioimmunoassay (RIA) (125I) urine cannabinoid immunoassays by gas chromatographic/mass spectrometric (GC/MS) and bonded-phase adsorption/thin-layer chromatographic (BPA-TLC) methods. Kogan MJ; Al Razi J; Pierson DJ; Willson NJ J Forensic Sci; 1986 Apr; 31(2):494-500. PubMed ID: 3011956 [TBL] [Abstract][Full Text] [Related]
16. Interference with testing for lysergic acid diethylamide. Ritter D; Cortese CM; Edwards LC; Barr JL; Chung HD; Long C Clin Chem; 1997 Apr; 43(4):635-7. PubMed ID: 9105265 [TBL] [Abstract][Full Text] [Related]
17. Confirmation of LSD intoxication by analysis of serum and urine. McCarron MM; Walberg CB; Baselt RC J Anal Toxicol; 1990; 14(3):165-7. PubMed ID: 2374406 [TBL] [Abstract][Full Text] [Related]
18. Determination of lysergic acid diethylamide (LSD) in urine by instrumental high-performance thin-layer chromatography. Blum LM; Carenzo EF; Rieders F J Anal Toxicol; 1990; 14(5):285-7. PubMed ID: 2263062 [TBL] [Abstract][Full Text] [Related]
19. Immunoassay screening of lysergic acid diethylamide (LSD) and its confirmation by HPLC and fluorescence detection following LSD ImmunElute extraction. Grobosch T; Lemm-Ahlers U J Anal Toxicol; 2002 Apr; 26(3):181-6. PubMed ID: 11991536 [TBL] [Abstract][Full Text] [Related]
20. The development and application of a gas chromatography-mass spectrometric (GC-MS) assay to determine the presence of 2-oxo-3-hydroxy-LSD in urine. Burnley BT; George S J Anal Toxicol; 2003; 27(4):249-52. PubMed ID: 12820748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]